Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review
about
Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016Direct-Acting Oral Anticoagulants: Practical Considerations for Emergency Medicine PhysiciansManagement of Venous Thromboembolism: Recent Advances in Oral Anticoagulation TherapyGuidance for the evaluation and treatment of hereditary and acquired thrombophiliaIncreased Thromboembolic Events With Dabigatran Compared With Vitamin K Antagonism in Left Ventricular Assist Device Patients: A Randomized Controlled Pilot TrialSafety of The Direct Oral Anticoagulant Edoxaban for Atrial Fibrillation After Cardiac Surgery: Pilot Study.Evaluating coagulation tests in patients with atrial fibrillation using direct oral anticoagulants.Laboratory measurement of the direct oral anticoagulants.ANMCO Position Paper: direct oral anticoagulants for stroke prevention in atrial fibrillation: clinical scenarios and future perspectives.Quality laboratory issues in bleeding disorders.Optimal utilization of thrombophilia testing.The danger of relying on the APTT and PT in patients on DOAC therapy, a potential patient safety issue.Influence of Direct Oral Anticoagulants on Anti-Factor Xa Measurements Utilized for Monitoring Heparin.The anticoagulant effect of heparin during radiofrequency ablation (RFA) in patients taking apixaban or rivaroxaban.Idarucizumab for Reversal of Dabigatran Prior to Acute Surgery: A Schematic Approach Based on a Case Report.
P2860
Q26743727-D166B9A9-C6F5-4F3B-AF7C-FEF6743178B0Q26746917-87F11BA1-AADA-4B76-8341-D826D1AE8A59Q26766303-0B3FF551-BFF4-4228-96E6-3804BCAFF05BQ28077943-7697A110-41DC-4A2A-B341-D06F539C2EC2Q33698353-DFB31B34-C19A-4807-BB77-D7CC0E3D72DDQ37723884-625D2AF1-0443-487A-8568-9E5FBB12BCF0Q38608242-9DBE58BB-459B-42B2-A6C0-A686E4D6D72DQ38613869-01B96B3F-9D7D-4355-96CD-EB9D38597AC5Q38650658-D08D7C3E-DDCE-4880-B6F8-10DF850F2C12Q38894179-308F7A13-D654-4F40-BC9C-0DA6A2CBEC81Q39266304-E1C511ED-BED9-448D-AE1A-A2F245AF9713Q39266324-AB84B28E-4F36-4E52-A727-E9A052CEEA7FQ50237696-D85F0AB0-C9A2-48F9-B093-15AA0F14E22DQ50522392-A6C33591-246E-4CD6-9D84-AE5C2072E684Q51353817-D174D5D0-00B4-46E0-9832-9EC9137D0703
P2860
Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review
@ast
Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review
@en
Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review
@nl
type
label
Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review
@ast
Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review
@en
Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review
@nl
prefLabel
Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review
@ast
Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review
@en
Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review
@nl
P3181
P1433
P1476
Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review
@en
P2093
D.M. Adcock
R. Gosselin
P3181
P356
10.1016/J.THROMRES.2015.05.001
P407
P577
2015-07-01T00:00:00Z